These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25754289)

  • 1. A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence.
    Bockting CL; Hollon SD; Jarrett RB; Kuyken W; Dobson K
    Clin Psychol Rev; 2015 Nov; 41():16-26. PubMed ID: 25754289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study.
    Bockting CL; Spinhoven P; Wouters LF; Koeter MW; Schene AH;
    J Clin Psychiatry; 2009 Dec; 70(12):1621-8. PubMed ID: 20141705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis.
    Zhang Z; Zhang L; Zhang G; Jin J; Zheng Z
    BMC Psychiatry; 2018 Feb; 18(1):50. PubMed ID: 29475431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.
    Farb N; Anderson A; Ravindran A; Hawley L; Irving J; Mancuso E; Gulamani T; Williams G; Ferguson A; Segal ZV
    J Consult Clin Psychol; 2018 Feb; 86(2):200-204. PubMed ID: 29265831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: A 10 year follow-up of a randomized controlled trial.
    Bockting CL; Smid NH; Koeter MW; Spinhoven P; Beck AT; Schene AH
    J Affect Disord; 2015 Oct; 185():188-94. PubMed ID: 26188380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial.
    Bockting CL; Schene AH; Spinhoven P; Koeter MW; Wouters LF; Huyser J; Kamphuis JH
    J Consult Clin Psychol; 2005 Aug; 73(4):647-57. PubMed ID: 16173852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis.
    Piet J; Hougaard E
    Clin Psychol Rev; 2011 Aug; 31(6):1032-40. PubMed ID: 21802618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mindfulness predicts relapse/recurrence in major depressive disorder after mindfulness-based cognitive therapy.
    Michalak J; Heidenreich T; Meibert P; Schulte D
    J Nerv Ment Dis; 2008 Aug; 196(8):630-3. PubMed ID: 18974675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.
    Guidi J; Tomba E; Fava GA
    Am J Psychiatry; 2016 Feb; 173(2):128-37. PubMed ID: 26481173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
    Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
    Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE
    J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
    Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
    J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
    Vittengl JR; Anna Clark L; Thase ME; Jarrett RB
    Psychiatry Res; 2017 Jul; 253():174-181. PubMed ID: 28388454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.
    Shallcross AJ; Gross JJ; Visvanathan PD; Kumar N; Palfrey A; Ford BQ; Dimidjian S; Shirk S; Holm-Denoma J; Goode KM; Cox E; Chaplin W; Mauss IB
    J Consult Clin Psychol; 2015 Oct; 83(5):964-75. PubMed ID: 26371618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential predictors of response to preventive cognitive therapy in recurrent depression: a 2-year prospective study.
    Bockting CL; Spinhoven P; Koeter MW; Wouters LF; Visser I; Schene AH;
    Psychother Psychosom; 2006; 75(4):229-36. PubMed ID: 16785772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse and recurrence prevention in depression: current research and future prospects.
    Beshai S; Dobson KS; Bockting CL; Quigley L
    Clin Psychol Rev; 2011 Dec; 31(8):1349-60. PubMed ID: 22020371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial.
    Stangier U; Hilling C; Heidenreich T; Risch AK; Barocka A; Schlösser R; Kronfeld K; Ruckes C; Berger H; Röschke J; Weck F; Volk S; Hambrecht M; Serfling R; Erkwoh R; Stirn A; Sobanski T; Hautzinger M
    Am J Psychiatry; 2013 Jun; 170(6):624-32. PubMed ID: 23732968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    J Affect Disord; 2016 Jul; 199():148-56. PubMed ID: 27104803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Rogier A; Donders T; Speckens AE
    Br J Psychiatry; 2016 Apr; 208(4):366-73. PubMed ID: 26892847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects.
    Ma SH; Teasdale JD
    J Consult Clin Psychol; 2004 Feb; 72(1):31-40. PubMed ID: 14756612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.